GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (GREY:ADDXF) » Definitions » Shiller PE Ratio

Addex Therapeutics (Addex Therapeutics) Shiller PE Ratio : (As of Jun. 10, 2024)


View and export this data going back to . Start your Free Trial

What is Addex Therapeutics Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Addex Therapeutics Shiller PE Ratio Historical Data

The historical data trend for Addex Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Shiller PE Ratio Chart

Addex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Addex Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Addex Therapeutics's Shiller PE Ratio

For the Biotechnology subindustry, Addex Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Addex Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Addex Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Addex Therapeutics's Shiller PE Ratio falls into.



Addex Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Addex Therapeutics's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Addex Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/107.3549*107.3549
=0.000

Current CPI (Mar. 2024) = 107.3549.

Addex Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200912 -3.903 101.610 -4.124
201006 -2.674 102.102 -2.812
201012 -2.766 102.138 -2.907
201106 -2.464 102.678 -2.576
201112 -2.271 101.408 -2.404
201206 -2.015 101.596 -2.129
201212 -1.552 100.968 -1.650
201306 -1.725 101.466 -1.825
201312 0.011 101.036 0.012
201406 -0.112 101.517 -0.118
201412 -0.082 100.704 -0.087
201506 -0.279 100.464 -0.298
201512 -0.131 99.386 -0.142
201606 -0.134 100.088 -0.144
201612 -0.147 99.380 -0.159
201706 -0.145 100.285 -0.155
201712 -0.111 100.213 -0.119
201806 0.101 101.435 0.107
201812 -0.192 100.906 -0.204
201903 -0.120 101.571 -0.127
201906 -0.172 102.044 -0.181
201909 -0.141 101.396 -0.149
201912 -0.142 101.063 -0.151
202003 -0.167 101.048 -0.177
202006 -0.126 100.743 -0.134
202009 -0.131 100.585 -0.140
202012 -0.090 100.241 -0.096
202103 -0.086 100.800 -0.092
202106 -0.154 101.352 -0.163
202109 -0.119 101.533 -0.126
202112 -0.141 101.776 -0.149
202203 -0.161 103.205 -0.167
202206 -0.196 104.783 -0.201
202209 -0.092 104.835 -0.094
202212 0.000 104.666 0.000
202303 0.000 106.245 0.000
202306 0.000 106.576 0.000
202309 0.000 106.570 0.000
202312 0.000 106.461 0.000
202403 0.000 107.355 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Addex Therapeutics  (GREY:ADDXF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Addex Therapeutics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Addex Therapeutics (Addex Therapeutics) Business Description

Traded in Other Exchanges
Address
Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202
Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (Addex Therapeutics) Headlines

From GuruFocus

Enamine Extend Collaboration With Prominent Swiss Biotech

By Business Wire Business Wire 02-24-2021